 |
|
Estimating the Population Prevalence of HPV
Susan C. Weller, PhD;
Lawrence R. Stanberry, MD, PhD
JAMA. 2007;297:876-878.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and HPV infection is associated with genital warts (HPV types 6 and 11) and cervical cancer (HPV types 16 and 18).1 In June 2006, the US Food and Drug Administration approved a vaccine against HPV types 6, 11, 16, and 18, and it is recommended for use in girls 11 and 12 years old.2
In this issue of JAMA, Dunne et al3 provide estimates of the 2003-2004 population prevalence of HPV in US women to establish a baseline against which postvaccine-era prevalence can be compared. Prevalence is the proportion of cases, new and old, that are present at a single point in time. To estimate the US population prevalence, a representative US sample must be used. Estimates of HPV prevalence based on specific clinic populations are . . . [Full Text of this Article]
Author Affiliations: Department of Preventive Medicine and Community Health (Dr Weller), and Department of Pediatrics (Dr Stanberry), Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston.
RELATED ARTICLE
Prevalence of HPV Infection Among Females in the United States
Eileen F. Dunne, Elizabeth R. Unger, Maya Sternberg, Geraldine McQuillan, David C. Swan, Sonya S. Patel, and Lauri E. Markowitz
JAMA. 2007;297(8):813-819.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
HPV Infection in U.S. Women: Who Has the Highest Prevalence?
JWatch Women's Health 2007;2007:3-3.
FULL TEXT
HPV Prevalence in U.S. Women
JWatch General 2007;2007:1-1.
FULL TEXT
|
